1. Willett HP. Streptococcus. ln: Joklik WK, Willett HP, Amos DB (eds). Zinsser Microbiology. 20 th. Ecl. Norwalk, Connecticut: Appleton & Lange; 1992 : 417.
2. Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 3 rd. ed. St. Louis, Missouri : Mosby in; 1998: 189.
3. Maria Jevitz Patterson, Samuel Baron , editors. In: Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 13.
4. Bisno AL. Streptococcus pyogenes. In: MarıdeI GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. 4 th. ed. New York: Churchill Livingstone; 1995: 1786.
5. Kilian M. Streptococcus and Lactobacillus. Collier L,: Salows A, Sussman M (eds). Topley and Wilson’s Microbiology and Microbial Infections. 9 th. ed. New York: Oxford University Press;
1998: 634.
6. Shakir SM, Gill R, Salberg J, Slechta ES, Feldman M, Fritsche T, Clarridge J, Sharp SE, Fisher MA. Clinical Laboratory Perspective on Streptococcus halichoeri, an Unusual Nonhemolytic,
Lancefield Group B Streptococcus Causing Human Infections. Emerg Infect Dis. 2021 May;27(5): 1309-1316.
7. Johnson CC, Tunkel AR. Viridans streptococci and groups C and G streptococci. ln: Mandel GL, Bennett JE, Dolin R (eds.) . Principles And Practice Of Infectious Diseases , 4 th. ed. New
York: Churchill Livingston. 1995; 1845.
8. Forbes BA, Sahm DF, Weissfeld A (Eds). Streptococcus, Enterococcus and similar organisms. In: Bailey and Scott’s Diagnostic Microbiology. 10 th. ed. St. Louis, Missouri: Mosby, Inc. 1998;
620.
STREPTOCOCCUS PYOGENES
KAYNAKLAR
1. Bryant AE, Stevens DL, Redel H, Blaser M; Streptococcus pyogenes. In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, Bennett JE, Dolin R, Blaser MJ 9th
Edition, Elsevier
2. Procop GW, Church DL, Hall GS, Janda WM, Koneman EW, Schreckenberger HC, et al. (Eds) Koneman’s Color Atlas and Textbook of Diagnostic Microbiology, Chapter 13: Gram-Positive
Cocci Part II: Streptococci, Enterococci and the “Streptococcus-Like” Bacteria, pp: 739-844. 2017, 7th Ed. Jones & Bartlett Publishers, Philadelphia.
3. Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol, 1996; 34 (4): 953-958.
4. Spellerberg B, Brandt C. Laboratory Diagnosis of Streptococcus pyogenes (group A streptococci) 2022 Sep 15 [Updated 2022 Oct 9]. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Strepto-
coccus pyogenes: Basic Biology to Clinical Manifestations [Internet]. 2nd edition. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2022 Oct 8. Chapter 29. Available
from: https://www.ncbi.nlm.nih.gov/books/NBK587110/
5. Newberger R, Hollingshead CM. Group A Streptococcal Infections. [Updated 2025 Jan 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK559240/
6. Carapetis JR, Steer AC, Mulholland EK, et al. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005; 5:685–94.
7. Ramírez de Arellano E, Saavedra-Lozano J, Villalón P, et al. Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a
context of global outbreak. mSphere. 2024 Mar 26;9(3):e0072923.
8. de Gier B, Marchal N, de Beer-Schuurman I, et al.; ISIS-AR Study Group. ISIS-AR Study Group; GAS Study group; de Melker HE, van Sorge NM; Members of the GAS study group; Mem-
bers of the ISIS-AR study group. Increase in invasive group A streptococcal (Streptococcus pyogenes) infections (iGAS) in young children in the Netherlands, 2022. Euro Surveill. 2023;
28:2200941.
9. Boeddha NP, Atkins L, de Groot R, et al.; EUCLIDS consortium. EUCLIDS consortium. Group A streptococcal disease in paediatric inpatients: a European perspective. Eur J Pediatr.
2023;182:697–706
10. Kizil MC, Kara Y, Bozan G, et al. Consecutive Seven Serious Cases with Invasive Group A Streptococcal Infections at December 2022-January 2023. Pediatr Infect Dis J. 2023 Jul
1;42(7):e254-e255.
11. Brouwer, S., Rivera-Hernandez, T., Curren, B.F. et al. Pathogenesis, epidemiology and control of Group A Streptococcus infection. Nat Rev Microbiol 2023, 21, 431–447.
12. Mosquera, J., & Pedreañez, A. (2020). Acute post-streptococcal glomerulonephritis: analysis of the pathogenesis. International Reviews of Immunology, 40(6), 381–400.
13. https://search.trdizin.gov.tr/en/yayin/detay/601976/turkiyede-grup-a-streptokoklarin-m-tiplendirilmesine-iliskin-ilk-epidemiyolojik-calisma
14. Topkaya AE, Balıkcı A, Aydın F, et al. Türkiye’de invazif streptokok enfeksiyonlarının epidemiyolojisi, klinik ve mikrobiyolojik özellikleri, 2010-2011 Mikrobiyol Bul. 2014;48(1):1-13.
15. Ünübol N, Caglayan N, Cebeci S, et al. Antimicrobial resistance and epidemiological patterns of Streptococcus pyogenes in Türkiye. J Infect Public Health. 2025 Feb;18(2):102633.
16. Su MS, Cheng Y, Lin Y, Wu J. 2024. Interplay between group A Streptococcus and host innate immune responses. Microbiol Mol Biol Rev 88:e00052-22.
17. Wolters, M., Berinson, B., Degel-Brossmann, N. et al. Population of invasive group A streptococci isolates from a German tertiary care center is dominated by the hypertoxigenic virulent
M1UK genotype. Infection 2024; 52, 667–671.
18. Cunningham MW, Kirvan CA. Post-Streptococcal Autoimmune Sequelae, Rheumatic Fever and Beyond: A New Perspective. 2024 Mar 12. In: Ferretti JJ, Stevens DL, Fischetti VA, editors.
Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]. 2nd edition. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2022 Oct 8. Chapter 28. Ava-
ilable from: https://www.ncbi.nlm.nih.gov/books/NBK606314/
19. Stevens DL, Bryant AE. Severe Streptococcus pyogenes Infections. 2022 Sep 7 [Updated 2022 Oct 4]. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: Basic Biology
to Clinical Manifestations [Internet]. 2nd edition. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2022 Oct 8. Chapter 24. Available from: https://www.ncbi.nlm.nih.
gov/books/NBK587112/
20. Sheraz S, Singh B, Munir A. Streptococcal Toxic Shock Syndrome – A Deadly and Rapidly Progressive Critical Illness [abstract]. Am J Respir Crit Care Med 2025;211:A3930.
21. Cohen JF, Bertille N, Cohen R, Chalumeau M. Rapid antigen detection test for group A Streptococcus in children with pharyngitis. Cochrane Database Syst Rev 2016; 7:CD010502.
22. Johnson DR, Kaplan EL, Bicova R, et al. Laboratory Diagnosis of Group A Streptococcal Infections. Geneva, Switzerland: World Health Organization; 1996.
23. Ikeda T, Suzuki R, Jin W, Wachino J, Arakawa Y, Kimura K. Isolation of Group A Streptococci with Reduced In Vitro β-Lactam Susceptibility Harboring Amino Acid Substitutions in Penicil-
lin-Binding Proteins in Japan. Antimicrob Agents Chemother 2021; 65:10.1128/aac.01482-21.
24. Dingle Yu, Danchun Guo, Yuejie Zheng, Yonghong Yang. A review of penicillin binding protein and group A Streptococcus with reduced-β-lactam susceptibility. Cell. Infect. Microbiol., 31
March 2023
25. Berbel, D.; González-Díaz, A.; López de Egea, G.; Càmara, J.; Ardanuy, C. An Overview of Macrolide Resistance in Streptococci: Prevalence, Mobile Elements and Dynamics. Microorganis-
ms 2022, 10, 2316.
STREPTOCOCCUS PNEUMONIAE
KAYNAKLAR
1. Murray PR, Rosenthal KS, Pfaller MA. Streptococcus and Enterococcus. In: Murray PR, Rosenthal KS, Pfaller MA (eds). Medical Microbiology, Philadelphia: Elsevier, Ninth Edition; 2021:
191-209.
2. Vollmer W, Massidda O, Tomasz A. The Cell Wall of Streptococcus pneumoniae. Microbiol Spectr 2019; 7(3).
3. Paton JC, Trappetti C. S. pneumoniae Capsular Polysaccharide. Microbiol Spectr 2019; 7:15.
4. Bandettini R, Melioli G. Laboratory diagnosis of S. pneumoniae infections: past and future. J Prev Med Hyg 2012; 53: 85-88.
5. Weiser JN, Ferreira DM, Paton JC. Streptococcus pneumoniae: transmission, colonization and invasion. Nat Rev Microbiol 2018; 16(6): 355-367.
6. Maestro B, Sanz JM. Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New Antimicrobials. Antibiotics (Basel) 2016; 5(2).
7. Galán-Bartual S, Pérez-Dorado I, García P, Hermoso JA. Chapter 11 ⁺ structure and function of choline-binding proteins. In: Brown J, Hammerschmidt S, Orihuela C, editors. Streptococcus
pneumoniae. Amsterdam: Academic Press; 2015. p. 207–30.
8. Muschiol S, Erlendsson S, Aschtgen M-S, Oliveira V, Schmieder P, de Lichtenberg C, et al. Structure of the competence pilus major pilin ComGC in Streptococcus pneumoniae. J Biol Chem
2017; 292(34): 14134–14146.
9. Ertugrul N. Rodriguez-Barradas MC, Musher DM. Ryan MAK. Agin CS. Murphy SC. Shayegani M, Watson DA: BOX-Polimerase Chain Reaction-Based DNA Analysis of Nonserotypeable
S. pneumoniae implicated in Outbreaks of Conjunktivitis. J Infect Dis 1997; 176:1401-1405.
10. Carr MA, Marcelo D, Lovell KM, Benton AH, Tullos NA, Norcross EW. Absence of S. pneumoniae Capsule Increases Bacterial Binding, Persistence, and Inflammation in Corneal Infecti-
on. Microorganisms 2022; 10(4): 710.
11. Marshall JE, Faraj BH, Gingras AR, Lonnen R, Sheikh MA, El-Mezgueldi M, et al. The crystal structure of pneumolysin at 2.0’a resolution reveals the molecular packing of the pre-pore comp-
lex. Sci Rep 2015; 5: 13293.
12. Winter AJ, Comis SD, Osborne MP, Tarlow MJ, Stephen J, Andrew PW, e al. A role for pneumolysin but not neuraminidase in the hearing loss and cochlear damage induced by experimental
pneumococcal meningitis in guinea pigs. Infect Immun 1997; 65(11): 4411-4418.
13. Gram-positive cocci Part II: Streptococci, Enterococci, and the “Streptococcus-like” bacteria. In: Jr Winn W, Allen S, Janda W, et al (eds). Koneman’s Color Atlas and Textbook of Diagnostic
Microbiology. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2017: 713-2015.
14. Whitsett JA, Alenghat T. Respiratory epithelial cells orchestrate pulmonary innate immunity. Nat Immunol 2015; 16(1): 27–35.
15. Zhang L, Li Z, Wan Z, Kilby A, Kilby JM, Jiang W. Humoral immune responses to S. pneumoniae in the setting of HIV-1 infection. Vaccine 2015; 33(36): 4430–6.
16. Hoe E, Anderson J, Nathanielsz J, Toh ZQ, Marimla R, Balloch A, et al. The contrasting role of Th17 immunity in human health and disease. Microbiol Immunol 2017; 61(2): 49–56.
17. Allen JC, McCulloch T, Kohle NV. Adult hemolytic uremic syndrome associated with Streptococcus pneumoniae. Clin Nephrol 2014; 82(2): 144–148.
18. Drijkoningen JJ, Rohde GG. Pneumococcal infection in adults: burden of disease. Clin Microbiol Infect 2014; 20:45–51.
19. Burçin Şener. Streptococcus pneumoniae. Enfeksiyon Hastalıkları ve Mikrobiyolojisi 1-2 Cilt, Prof. Editör: Dr. Ayşe Willke Topcu, Prof. Dr. Güner Söyletir, Prof. Dr. Mehmet Doğanay. 4.
Baskı. Sayfa: 1793-1797. Nobel Tıp Kitabevleri; 2017.
20. Sommerfleck P, González Macchi ME, Pellegrini S, Bernáldez P, Reijtman V, Hernández C, et al. Acute otitis media in infants younger than three months not vaccinated against Streptococcus
pneumoniae. Int J Pediatr Otorhinolaryngol 2013; 77(6): 976–980.
21. https://www.ecdc.europa.eu/en/pneumococcal-disease/facts, Page last updated 28 Nov 2023.
22. Brigante G, Luzzaro F, Bettaccini A, Lombardi G, Meacci F, Pini B, et al. Use of the Phoenix automated system for identification of Streptococcus and Enterococcus spp. J Clin Microbiol 2006;
44(9): 3263-7.
23. Ligozzi M, Bernini C, Bonora MG, De Fatima M, Zuliani J, Fontana R. Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant
gram-positive cocci. J Clin Microbiol 2002; 40(5): 1681-6.
24. Kanemitsu K, Kunishima H, Inden K, Hatta M, Harigae H, Ishizawa K, et al. Evaluation of the BD Phoenix SMIC/ID, a new streptococci identification and antimicrobial susceptibility panel,
for potential routine use in a university-based clinical microbiology laboratory. Diagn Microbiol Infect Dis 2005; 53(2): 101-5.
25. Sadowy E, Hryniewicz W. Identification of S. pneumoniae and other Mitis streptococci: importance of molecular methods. Eur J Clin Microbiol Infect Dis 2020; 39: 2247–2256.
26. Tavares DA Handem S, Carvalho RJ, Paulo AC, de Lencastre H, Hinds J, et al. Identification of S. pneumoniae by a real-time PZR assay targeting SP2020. Sci Rep 2019; 9: 3285.
27. Satzke C, Turner P, Virolainen-Julkunen A, Adrian PV, Antonio M, Hare KM, et al. WHO Pneumococcal Carriage Working Group. Standard method for detecting upper respiratory carriage
of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group. Vaccine 2013; 17;32(1): 165-79.
28. Harju I, Lange C, Kostrzewa M, Maier T, Rantakokko-Jalava K, Haanperä M. Improved Differentiation of S. pneumoniae and Other S. mitis Group Streptococci by MALDI Biotyper Using an
Improved MALDI Biotyper Database Content and a Novel Result Interpretation Algorithm. J Clin Microbiol 2017; 55(3): 914-922.
29. UK Standards for Microbiology Investigations, Identification of Streptococcus species, Enterococcus species and morphologically similar organisms Issued by the Standards Unit, National Infection
Service, PHE Identification 2021; 4(4): 1-31.
30. Van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009; 374: 1543–56.
31. King DT, Sobhanifar S, Strynadka NC. The mechanisms of resistance to β-lactam antibiotics. In: Gotte M, Berghuis A, Matlashewski G, Wainberg M, Sheppard D, editors. Handbook of An-
timicrobial Resistance. New York, NY: Springer; 2017: 177–201.
32. Jensen A, Valdorsson O, Frimodt-Moller N, Hollingshead S, Kilian M. Commensal streptococci serve as a reservoir for beta-lactam resistance genes in Streptococcus pneumoniae. Antimicrob
Agents Chemother 2015; 59(6): 3529–3540.
33. Cillóniz C, Garcia-Vidal C, Ceccato A, Torres A. Antimicrobial Resistance Among Streptococcus pneumoniae. Antimicrobial Resistance in the 21st Century 2018; 7: 13–38.
34. Specht M.V, García Gabarrot G, Mollerach M, Bonofiglio L, Gagetti P, Kaufman S, et al. Resistance to β-lactams in Streptococcus pneumoniae. Revista Argentina de Microbiología 2021; 53(3):
266-271.
35. Horna G, Molero ML, Benites L, Roman S, Carbajal L, Mercado E, et al. Oxacillin disk diffusion testing for the prediction of penicillin resistance in Streptococcus pneumoniae. Rev Panam
Salud Pública 2016 ;40: 57-63.
36. https://www.eucast.org. son erişim 09.04.2024
37. European Antimicrobial Resistance Surveillance System (EARSS). EARSS Annual Report 2021. (www.rivm.nl.earss)
38. Ceyhan M, Aykac K, Gurler N, Ozsurekci Y, Öksüz L, Akısoglu A, et al. Serotype distribution of Streptococcus pneumonia in children with invasive disease in Turkey: 2015-2018. Hum Vaccin
Immunother 2020; 16(11): 2773-2778.
39. Hascelik G, Soyletir G, Gulay Z, Sancak B, Yaman A, Gurler N, et al. Serotype distribution of S. pneumoniae and pneumococcal vaccine coverage in adults in Turkey between 2015 and 2018.
Ann Med 2022; 55(1): 266-275.
40. Wang JL, Lai C-C, Ko W-C, Hsueh P-R. Global trends in non-susceptibility rates of S. pneumoniae isolates to ceftriaxone: Data from the antimicrobial testing leadership and surveillance
(ATLAS) programme, 2016–21. Int J Antimicrob Agents 2024; 63(2): 107072.
41. Ak K, Arabacı Ç. Resistance of S. pneumoniae Strains Isolated from Clinical Samples to Various Antibiotics. Diclemedj 2020; 47(4): 779-786.
42. Safari D, Putri HFM, Bimantari A, Paramaiswari WT, Tafroji W, Khoeri MM, et al. Genetic characterization of co-trimoxazole non-susceptible S. pneumoniae isolates from Indonesia. Access
Microbiol 2021; 3(10): 000271.
43. Andrejko K, Ratnasiri B, Hausdorff W, Laxminarayan R, Lewnard JA. Antimicrobial resistance in paediatric S. pneumoniae isolates amid global implementation of pneumococcal conjugate
vaccines: a systematic review and meta-regression analysis. The Lancet Microbe 2021; 2(9): e450-460.
44. Alışkan H, Çolakoğlu Ş, Göçmen J.Antibiotic Resistance of S. pneumoniae and Haemophilus Influenzae Isolated from Respiratory Tract Specimens. Cukurova Med J 2016; 41(2): 201-7.
45. Şenol E, Azap A, Erbay A, Alp-Çavuş S, Karakuş R, Acar A. Pneumococcal vaccine as one of the immunization coverage targets for adulthood vaccines: A consensus report of the Study Group
for Adult Immunization of the Turkish Society of Clinical Microbiology and Infectious Diseases. Klimik Derg 2018; 31(Suppl. 1): 2-18.
46. U.S. Food and Drug Administration; Available from: https://www.fda.gov/vaccines-blood-biologics/vaccines/prevnar-20. Erişim tarihi: 10.09.2024.
47. European Medicines Agency; Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/vaxneuvance. Erişim tarihi: 10.09.2024.
48. Duke, J.A., Avci, F.Y. Emerging vaccine strategies against the incessant pneumococcal disease. npj Vaccines 2023; 8: 122.
VİRİDANS STREPTOKOKLAR
KAYNAKLAR
1. Sesin Kocagöz. Viridans Steptokoklar.Enfeksiyon Hastalıkları ve Mikrobiyolojisi 1-2 Cilt, Prof. Dr. Ayşe Willke Topcu, Prof. Dr. Güner Söyletir, Prof. Dr. Mehmet Doğanay. Sayfa: 1768-1772.
Nobel Tıp Kitabevleri. 2017
2. Menon T. Understanding the viridians group streptococci: Are we there yet? Indian J Med Microbiol 2016; 34:421-6.
3. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Washing ton CW, Procop GW, Woods GL: Koneman’s Color Atlas and Text book of Diagnostic Microbiology. 7 th Edition Lippincot
Williams and Wilkins, 2017. pp: 693-695.
4. Rezaei T, Mehramouz B, Gholizadeh P, Yousefi L, Ganbarov K, Ghotaslou R, et al. Factors associated with Streptococcus mutans pathogenicity in the oral cavity. Biointerface Res Appl Chem
2023; 13(4): 368.
5. Manzer HS, Nobbs AH, Doran K. S. The Multifaceted Nature of Streptococcal Antigen I/II Proteins in Colonization and Disease Pathogenesis. Front Microbiol 2020; 11: 602305.
6. Nobbs AH, Jenkinson HF, Everett DB. Generic determinants of streptococcus colonization and infection. Infect Genet Evol 2015; 33:361–370.
7. Rajani R, Klein JL. Infective endocarditis: A contemporary update. Clin Med (Lond) 2020; 20(1): 31-35.
8. Martini AM, Moricz BS, Ripperger AK, Tran PM, Sharp ME. ‘Association of novel Streptococcus sanguinis virulence factors with pathogenesis in a native valve infective endocarditis mo-
del’, Front Microbiol 2020; 11, 10.
9. Del Giudice C, Vaia E, Liccardo D, Marzano F, Valletta A, Spagnuolo G, et al. Infective Endocarditis: A Focus on Oral Microbiota. Microorganisms 2021; 9(6): 1218.
10. Turner LS, Kanamoto T, Unoki T, Munro CL, Wu H, Kitten T. Comprehensive evaluation of Streptococcus sanguinis cell wall-anchored proteins in early infective endocarditis. Infect Immu
2009; 77(11): 4966-75.
11. Qayyum H, Bakhtiar M. Pathogenomic Studies of Streptococcus sanguinis in Infective Endocarditis. Pakistan Journal of Pharmaceutical Research 2019; 5(2): 52-63.
12. Martini AM, Moricz BS, Woods LJ, Jones BD. Type IV Pili of Streptococcus sanguinis Contribute to Pathogenesis in Experimental Infective Endocarditis. Microbiol Spectr 2021; 9(3):
e0175221.
13. Martin DR, Witten JC, Tan CD, Rodriguez ER, Blackstone EH, Pettersson GB, Seifert DE, Willard BB, Apte SS. Proteomics identifies a convergent innate response to infective endocarditis
and extensive proteolysis in vegetation components. JCI Insight 2020; 5(14): e135317.
14. Braï MA, Hannachi N, El Gueddari N, Baudoin JP, Dahmani A, Lepidi H, Habib G, Camoin-Jau L. The Role of Platelets in Infective Endocarditis. Int J Mol Sci 2023; 24(8): 7540.
15. Guerrero-Del-Cueto F, Ibanes-Gutiérrez C, Velázquez-Acosta C, Cornejo-Juárez P, Vilar-Compte D. Microbiology and clinical characteristics of viridans group streptococci in patients with
cancer. The Braz J Infect Dis 2018; 22 (4): 323 – 327.
16. Zecha J.A.E.M, Raber-Durlacher J.E, Laheij A.M.G.A, Westermann W.B, Epstein J.B, Lange J, et al. The impact of the oral cavity in febrile neutropenia and infectious complications in patients
treated with myelosuppressive chemotherapy. Support Care Cancer 2019; 27: 3667-3679.
17. Plainvert C, Matuschek E, Dmytruk N, Gaillard M, Frigo A, Ballaa Y, et al. Microbiological Epidemiology of Invasive Infections Due to Non-Beta-Hemolytic Streptococci, France 2021.
Microbiol Spectr 2023; 11: e00160-23.
18. Johannsen KH, Handrup MM, Lausen B, Schrøder H, Hasle H. High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine. Pediatr Blood
Cancer 2013; 60(7): 1154–1160.
19. Wierenga J.R. Emergent Fluoroquinolone Resistance in Viridans Streptococcal Species in Cancer Patients. Diss. 2014.
20. Shelburne SA, Sahasrabhojane P, Saldana M, Yao H, Su X, Horstmann N, Thompson E, Flores AR. Streptococcus mitis strains causing severe clinical disease in cancer patients. Emerg Infect
Dis 2014; 20(5): 762-71.
21. Han XY, Kamana M, Rolston KV. Viridans streptococci isolated by culture from blood of cancer patients: clinical and microbiological analysis of 50 cases. J Clin Microbiol 2006; 44: 160–165.
22. Chaemsaithong P, Lertrut W, Kamlungkuea T, Santanirand P, Singsaneh A, Jaovisidha A, et al. Maternal septicemia caused by Streptococcus mitis: a possible link between intra-amniotic infe-
ction and periodontitis. Case report and literature review. BMC Infect Dis 2022; 22: 562.
23. Fukushima K, Noda M, Saito Y, Ikeda T. Streptococcus sanguis meningitis: report of a case and review of the literature. Intern Med 2012;51(21):3073-6.
24. Zbinden A, Mueller NJ, Tarr PE, Spröer C, Keller PM, Bloemberg GV. Streptococcus tigurinus sp. nov., isolated from blood of patients with endocarditis, meningitis and spondylodiscitis. Int J Syst
Evol Microbiol. 2012; 62(12): 2941-2945.
25. Liu Y.T, Lin C.F, Lee Y.L. Streptococcus sanguinis meningitis following endoscopic ligation for oesophageal variceal haemorrhage. Journal of Medical Microbiology 2013;62: 794–796
26. Esposito S, Mayer A, Krzysztofiak A, Garazzino S, Lipreri R, Galli L, et al. Infective Endocarditis in Children in Italy from 2000 to 2015. Expert Rev Anti-Infect Ther 2016; 14: 353–358.
27. Nakamura Y, Uemura T, Kawata Y, Hirose B, Yamauchi R, Shimohama S. Streptococcus oralis Meningitis with Gingival Bleeding in a Patient: A Case Report and Review of the Literature.
Intern Med 2021; 60(5): 789-793.
28. Yanagida M, Hosoi Y, Kawano T, Otake Y, Yamanaka Y, Baba T, Ito M. Noniatrogenic Meningitis Caused by Streptococcus salivarius Associated with Early Esophageal Cancer and Early Gastric
Cancer. Intern Med 2024; 63(3): 457-460.
29. Ruderman B, Thoureen T, Broder J. Viridans streptococci Intracranial Abscess Masquerading as Metastatic Disease. JETem 2018; 3(1): 7-8.
30. Bodilsen J, D’Alessandris Q, Humphreys H, A. Iro M, Klein M, Last K, et.al. European society of Clinical Microbiology and Infectious Diseases guidelines on diagnosis and treatment of brain
abscess in children and adults. Clin Microbiol Infect 2024; 30(1): 654–656.
31. Choi SH, Cha SI, Choi KJ, Lim JK, Seo H, Yoo SS, et al. Clinical Characteristics of Community-Acquired Viridans Streptococcal Pneumonia. Tuberc Respir Dis (Seoul) 2015; 78(3): 196-202.
32. Hashimoto M, Ueda K, Nakao T, Tanaka T, Komuro I. Vertebral osteomyelitis secondary to infective endocarditis detected by repeated magnetic resonance imaging: a case report. Eur Heart
J Case Rep. 2023; 7(11): ytad552.
33. Feder OI, Gruson KI. Glenohumeral Joint Sepsis Caused by Streptococcus mitis: A Case Report. Am J Orthop (Belle Mead NJ) 2016; 45(6): E343-E346.
34. Lu H-Z, Weng X-H, Zhu B, et. Al. Major outbreak of toxic shocklike syndrome caused by Streptococcus mitis. J Clin Microbiol 2003; 41: 3051-3055.
35. Lal D, Verma M, Lal R. Exploring internal features of 16S rRNA gene for identification of clinically relevant species of the genus Streptococcus. Ann Clin Microbiol Antimicrob 2011; 10: 28.
36. Kosecka-Strojek M, Wolska M, Żabicka D, Sadowy E, Międzobrodzki J. Identification of Clinically Relevant Streptococcus and Enterococcus Species Based on Biochemical Methods and 16S
rRNA, sodA, tuf, rpoB, and recA Gene Sequencing. Pathogens 2020; 9(11): 939.
37. Paul B. Concatenated 16S rRNA sequence analysis improves bacterial taxonomy. F1000Research, 2022; 11.
38. Nix ID, Idelevich EA, Schlattmann A, Sparbier K, Kostrzewa M, Becker K. MALDI-TOF Mass Spectrometry-Based Optochin Susceptibility Testing for Differentiation of Streptococcus pneu-
moniae from other Streptococcus mitis Group Streptococci. Microorganisms 2021; 9(10): 2010.
39. Wan T, Lee T, Chen X, Hunag Y, Teng L, Hsueh P, Chiu H. Performance assessment of the Bruker Biotyper MALDI-TOF MS for the identification of difficult-to-identify viridans group
streptococci. J Clin Microbiol 2023; 61: e01143-23.
40. CLSI. 2017. Methods for the identification of cultured microorganisms using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, 1st ed. CLSI guideline M58. Wayne,
PA Clinical and Laboratory Standards Institute
41. Lee YJ, Kim M, Kim J, Kim J. Detection of Streptococcus mutans in human saliva and plaque using selective media, polymerase chain reaction, and monoclonal antibodies. Oral Biol Res
2019; 43: 121-129.
42. Tao Y, Zhou Y, Ouyang Y, Lin H. C. Association of oral streptococci community dynamics with severe early childhood caries as assessed by PZR-denaturing gradient gel electrophoresis
targeting the rnpB gene. J Med Microbiol 2015; 64(8): 936–945.
43. Kawamura Y, Hou XG, Sultana F, Miura H, Ezaki T. Determination of 16S rRNA sequences of Streptococcus mitis and Streptococcus gordonii and phylogenetic relationships among members
of the genus Streptococcus. Int J Syst Bacteriol 1995; 45(2): 406-8.
44. Singh N, Poggensee L, Huang Y, Evans CT, Suda KJ, Bulman ZP. Antibiotic susceptibility patterns of viridans group streptococci isolates in the United States from 2010 to 2020. JAC Antimic-
rob Resist 2022; 4(3): dlac049.
45. Lopardo HA, Vigliarolo L, Bonofiglio L, Gagetti P, García Gabarrot G, Kaufman S, et al. Beta-lactam antibiotics and viridans group streptococci. Rev Argent Microbiol 2022; 54(4): 335-343.
46. Gordon KA, Beach ML, Biedenbach DJ, Jones RN, Rhomberg PR, Mutnick AH. Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the
SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis 2002; 43(2): 157-62.
47. Van Prehn J, van Triest MI, Altorf-van der Kuil Wet al. Third-generation cephalosporin and carbapenem resistance in Streptococcus mitis/oralis. Results from a nationwide registry in the
Netherlands. Clin Microbiol Infect 2019; 25: 518–20.
48. Pfaller MA, Huband MD, Shortridge D, Flamm RK. Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY
Antimicrobial Surveillance Program, 2016 to 2018. Antimicrob Agents Chemother 2020; 64(5): e02488-19.
49. Heine A.C, García S, Barberis C, Vay C, Mollerach M, Bonofiglio L, et al. Identificación y sensibilidad a los antimicrobianos de aislados de estreptococos del grupo viridans provenientes de
pacientes internados en un hospital universitario de la ciudad de Buenos Aires. Rev Argent Microbiol 2019; 51: 26-31.
50. Berbel D, González-Díaz A, López de Egea G, Càmara J, Ardanuy C. An Overview of Macrolide Resistance in Streptococci: Prevalence, Mobile Elements and Dynamics. Microorganisms 2022;
10: 2316.
51. Ergin, A.; Ercis, S.; Hasçelik, G. Macrolide Resistance Mechanisms and in Vitro Susceptibility Patterns of Viridans Group Streptococci Isolated from Blood Cultures. J Antimicrob Chemother
2006; 57: 139–141.
52. Mendes R.E, Castanheira M, Farrell D.J, Flamm R.K, Sader H.S, Jones R.N. Prevalence of Macrolide–Lincosamide Resistance and Multidrug Resistance Phenotypes in Streptococcal Isolates
Causing Infections in European Hospitals: Evaluation of the in Vitro Activity of Oritavancin and Comparator Agents. J Glob Antimicrob Resist 2017; 8: 28–32.
53. Chun S, Huh H. J, Lee N. Y. Species-specific difference in antimicrobial susceptibility among viridans group streptococci. Ann Lab Med 2015; 35(2): 205-211.
54. Mishra NN, Tran TT, Seepersaud R, Garcia-de-la-Maria C, Faull K, Yoon A, et al. Perturbations of Phosphatidate Cytidylyltransferase (CdsA) Mediate Daptomycin Resistance in Streptococ-
cus mitis/oralis by a Novel Mechanism. Antimicrob Agents Chemother 2017; 61(4): e02435-16.
55. Desai N, Steenbergen J, Katz DE. Antibiotic Resistance of Non-pneumococcal Streptococci and Its Clinical Impact. Antimic Drug Resistance 2016: 791–810.
DİĞER STREPTOKOKLAR
KAYNAKLAR
1. Lancefield RC. A serological differentiation of human and other groups of hemolytic streptococci. J Exp Med 1935; 57 (4): 578.
2. Haslam DB, St. Geme JW. Classification of streptococci. In: Long SS, Pickering LK, Prober CG (eds). Principles and Practice of Pediatric Infectious Diseases. 4th ed. Philadelphia: Mosby
Saunders Elsevier, 2012: 695-698.
3. Sinner SW, Tunkel AR. Viridans streptococci, groups C and G streptococci, and Gemella. In: Mandell GL, Bennett JE, Dolin R (eds). Mandell, Douglas and Bennett’s Principles and Practice
of Infectious Diseases. 7th ed. Boston: Churchill Livingstone Elsevier, 2010: 2667-2680.
4. Gram-positive cocci Part II: Streptococci, Enterococci, and the “Streptococcus-like” bacteria. In: Jr Winn W, Allen S, Janda W, et al (eds). Koneman’s Color Atlas and Textbook of Diagnostic
Microbiology.
5. 6th ed. Philadelphia: Lippincott Williams and Wilkins, 2017: 713-2015.
6. Baracco GJ. Infections Caused by Group C and G Streptococcus (Streptococcus dysgalactiae subsp. equisimilis and Others): Epidemiological and Clinical Aspects. Microbiol Spectr 2019; 7(2):
11-22.
7. Silva LG, Genteluci GL, Corrêa de Mattos M, Glatthardt T, Sá Figueiredo AM, Ferreira-Carvalho BT. Group C Streptococcus dysgalactiae subsp. equisimilis in south-east Brazil: genetic
diversity, resistance profile and the first report of human and equine isolates belonging to the same multilocus sequence typing lineage. J Med Microbiol 2015; 64(5): 551-558.
8. Turner CE.Bubba L.Efstratiou A. 2019. Pathogenicity Factors in Group C and G Streptococci. Microbiol Spectr 7: 10.1128.
9. Bramhachari PV, Kaul SY, McMillan DJ, Shaila MS, Karmarkar MG, Sriprakash KS. Disease burden due to Streptococcus dysgalactiae subsp. equisimilis (group G and C streptococcus) is
higher than that due to Streptococcus pyogenes among Mumbai school children. J Med Microbiol 2010; 59(2): 220-223.
10. Kłos M, Wójkowska-Mach J. Pathogenicity of Virulent Species of Group C Streptococci in Human. Can J Infect Dis Med Microbiol 2017; 2017: 9509604.B
11. Lynskey NN, Reglinski M, Calay D, Siggins MK, Mason JC, Botto M, et al. Multi-functional mechanisms of immune evasion by the streptococcal complement inhibitor C5a peptidase. PLoS
Pathog 2017; 13(8): e1006493.
12. Andreoni F, Ugolini F, Keller N, Neff A, Nizet V, Hollands A, et al. Immunoglobulin attenuates streptokinase-mediated virulence in Streptococcus dysgalactiae subsp. equisimilis necrotizing
fasciitis. J Infect Dis 2017; 217: 270–279.
13. Commons RJ, Smeesters PR, Proft T, Fraser JD, Robins-Browne R, Curtis N. Streptococcal superantigens: categorization and clinical associations. Trends Mol Med 2014; 20: 48–62.
14. Paspaliari DK, Sarvikivi E, Ollgren J, Vuopio J. Invasive beta-haemolytic streptococcal infections, Finland, 2006 to 2020: increase in Lancefield group C/G infections. Euro Surveill 2023;
28(31): 2200807.
15. Handford C, Kalogrianitis S. A rare case of spontaneous acute bacterial arthritis of the glenohumeral joint attributed to Streptococcus dysgalactiae subsp. equisimilis. Int J Shoulder Surg 2015;
9: 100–101.
16. Oppegaard O, Mylvaganam H, Skrede S, Kittang BR. Exploring the arthritogenicity of Streptococcus dysgalactiae subspecies equisimilis. BMC Microbiol 2018; 17.
17. Galloway A, Noel I, Efstratiou A, Saint E, White DR. An outbreak of group C streptococcal infection in a maternity unit. J Hosp Infect 1994; 28: 31.
18. Jaalama M, Palomäki O, Vuento R, Jokinen A, Uotila J. Prevalence and Clinical Significance of Streptococcus dysgalactiae subspecies equisimilis (Groups C or G Streptococci) colonization in
Pregnant Women: A Retrospective Cohort Study. Infect Dis Obstet Gynecol 2018; (1): 2321046.
19. Tarakci N, Yılmaz FH, Gültekin ND, Altunhan H, Örs R. Neonatal meningitis due to streptoccocus dysgalactiae subspecies equisimilis: a case report and literature review. J Clin Anal Med
2018; 9(3): 254-6.
20. Ruppen C, Rasmussen M, Casanova C, Sendi P. 10-year observational study of Streptococcus dysgalactiae bacteraemia in adults: frequent occurrence among female intravenous drug users.
Swiss Med Wkly 2017; 147: w14469.
21. Kawakami V, Rietberg K, Lipton B, Eckmann K, Watkins M, Oltean H, et al. Fatal infection associated with equine exposure – King County, Washington, 2016. MMWR Morb Mortal Wkly
Rep 2016; 65: 788.
22. Lother SA, Jassal DS, Lagacé-Wiens P, Keynan Y. Emerging group C and group G streptococcal endocarditis: a Canadian perspective. Int J Infect Dis 2017; 65: 128–132.
23. Nybakken EJ, Oppegaard O, Gilhuus M, Salgård Jensen C, Mylvaganam H. Identification of Streptococcus dysgalactiae using matrix-assisted laser desorption/ionization-time of flight mass
spectrometry; refining the database for improved identification. Diagn Microbiol Infect Dis 2021; 99(1): 115207.
24. Arabacı Ç, Ak K. Beta hemolytic Streptococci strains isolated from clinical specimens; their characteristics and antibiotic susceptibility. J Surg Med. 2020; 4(1): 00-00.
25. Pilarczyk-Zurek M, Sitkiewicz I, Koziel J. The Clinical View on Streptococcus anginosus Group – Opportunistic Pathogens Coming Out of Hiding. Front Microbiol 2022; 13: 956677.
26. Ayşe Esra Karakoç. Diğer Steptokoklar.Enfeksiyon Hastalıkları ve Mikrobiyolojisi 1-2 Cilt, Prof. Dr. Ayşe Willke Topcu, Prof. Dr. Güner Söyletir, Prof. Dr. Mehmet Doğanay. Sayfa: 1789-1792.
Nobel Tıp Kitabevleri. 2017
27. Terzi HA, Demiray T, Koroglu M, Cakmak G, Hakki Ciftci I, Ozbek A, Altindis M. Intra-Abdominal Abscess and Primary Peritonitis Caused by Streptococcus anginosus. Jundishapur J
Microbiol 2016; 9(6): e33863.
28. Woods K, Beighton D, Klein J. L. Identification of the ‘Streptococcus anginosus group’ by matrix-assisted laser desorption ionization–time-of-flight mass spectrometry. J. Med. Microbiol 2014;
63): 1143–1147.
29. Kozińska, A., Seweryn, P., and Sitkiewicz, I. A crash course in sequencing for a microbiologist. J. Appl. Genet 2019; (60): 103–111.
30. Dekker JP, Lau AF. An Update on the Streptococcus bovis Group: Classification, Identification, and Disease Associations. J Clin Microbiol 2016; 54(7): 1694-1699.
31. Şahin T, Kiliç O, Acar AG, Severoğlu Z. A review: the role of Streptococcus bovis in colorectal cancer. Art Human Open Acc J 2023; 5(3): 165‒173.
32. Corredoira J, Alonso MP, Coira A, Varela J. Association between Streptococcus infantarius (formerly S. bovis II.1) bacteremia and noncolonic cancer. J Clin Microbiol 2008; 46: 1570.
33. van Samkar A, Brouwer MC, Pannekoek Y, van der Ende A, van de Beek D. Streptococcus gallolyticus meningitis in adults: report of five cases and review of the literature. Clin Microbiol
Infect 2015; 21: 1077–1083.
34. Beck M, Frodl R, Funke G. Comprehensive study of strains previously designated Streptococcus bovis consecutively isolated from human blood cultures and emended description of Strepto-
coccus gallolyticus and Streptococcus infantarius subsp. coli. J Clin Microbiol 2008; 46: 2966–2972.
35. Youn JH, Wallace M, Burnham C-AD, Butler-Wu S, Frank KM, Dekker JP, Lau AF. Accurate identification with the Streptococcus bovis group: performance of the Bruker Biotyper, Vitek MS,
Vitek 2, and sodA and 16S rDNA sequencing. 115th Gen Meet Am Soc Microbiol, New Orleans, LA. American Society for Microbiology, Washington, DC. 2015.
36. Öberg J, Inghammar M, Nilson B. Improved identification of Streptococcus bovis-Streptococcus equinus-complex species and subspecies by MALDI-TOF MS using a novel library. Diagn
Microbiol Infect Dis 2023; 107(3): 116045.
37. Agergaard CN, Knudsen E, Dargis R, Nielsen XC, Christensen JJ, Justesen US. Species identification of Streptococcus bovis group isolates causing bacteremia: a comparison of two MAL-
DI-TOF MS systems. Diagn Microbiol Infect Dis 2017; 88(1): 23-25.
38. Pompilio A, Di Bonaventura G, Gherardi G. An Overview on Streptococcus bovis/Streptococcus equinus Complex Isolates: Identification to the Species/Subspecies Level and Antibiotic Resis-
tance. Int J Mol Sci 2019; 20(3): 480.
39. Poyart C, Pierre C, Quesne G, Pron B, Berche P, Trieu-Cuot P. Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Strep-
tococcus bovis. Antimicrob Agents Chemother 1997; 41(1): 24-9.